PHOSPHOSYNVAX Trademark

Trademark Overview

On Tuesday, December 29, 2015, a trademark application was filed for PHOSPHOSYNVAX with the United States Patent and Trademark Office. The USPTO has given the PHOSPHOSYNVAX trademark a serial number of 86860907. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2019. This trademark is owned by AGENUS INC.. The PHOSPHOSYNVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease
phosphosynvax

General Information

Serial Number86860907
Word MarkPHOSPHOSYNVAX
Filing DateTuesday, December 29, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2016

Trademark Statements

Goods and ServicesPharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 8, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAGENUS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 024217305
Party NameAGENUS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 024217305

Trademark Events

Event DateEvent Description
Monday, August 19, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 19, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 29, 2019EXTENSION 5 GRANTED
Thursday, January 17, 2019EXTENSION 5 FILED
Tuesday, January 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 17, 2019TEAS EXTENSION RECEIVED
Friday, July 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 11, 2018EXTENSION 4 GRANTED
Wednesday, July 11, 2018EXTENSION 4 FILED
Wednesday, July 11, 2018TEAS EXTENSION RECEIVED
Saturday, January 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2018EXTENSION 3 GRANTED
Thursday, January 18, 2018EXTENSION 3 FILED
Thursday, January 18, 2018TEAS EXTENSION RECEIVED
Friday, July 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 19, 2017EXTENSION 2 GRANTED
Wednesday, July 19, 2017EXTENSION 2 FILED
Wednesday, July 19, 2017TEAS EXTENSION RECEIVED
Thursday, January 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2017EXTENSION 1 GRANTED
Tuesday, January 17, 2017EXTENSION 1 FILED
Tuesday, January 17, 2017TEAS EXTENSION RECEIVED
Tuesday, July 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2016PUBLISHED FOR OPPOSITION
Monday, May 16, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 16, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 4, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 19, 2016ASSIGNED TO LIE
Friday, April 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 17, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, March 17, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 17, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, March 17, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, March 11, 2016ASSIGNED TO EXAMINER
Friday, January 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 1, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

phosphosynvax disease agents namely cancers disorders autoimmune infectious transplant inflammatory rejection